Lynch syndrome screening for patients with bowel cancer diagnosed before age 70 is cost effective given the potential for identifying at-risk family members who would benefit from intensive surveillance. However the additional cases detected compared to only screening younger patients come at a cost. The Australian study also found that screening with MMR immunohistochemistry then ...
Weighing up the cost of Lynch syndrome screening
By Mardi Chapman
19 Apr 2018